Sign In
Buy EMP
$20.51
-0.215 (-1.04%)
At Close: Jun 22, 2026
Poland's EMP teams up with Foxconn to build EV manufacturing hub
04:43am, Thursday, 07'th May 2026
State-backed ElectroMobility Poland said Thursday it will partner with Taiwan's Foxconn to develop an electric vehicle production and research hub in southern Poland, advancing plans to create a do
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by
Summary: Author and preparedness expert Ernie Williams' newly released book, "Wired for Disaster: How to Prepare for and Navigate a Post-EMP World," has reached #1 in multiple Amazon categories. The b
Empire Company Limited (EMP.A:CA) Q3 2026 Earnings Call Transcript
11:32am, Thursday, 12'th Mar 2026
Empire Company Limited (EMP.A:CA) Q3 2026 Earnings Call Transcript
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
07:00am, Thursday, 26'th Feb 2026
EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability profile EMP-01 demonstrated a clinically meaningful placebo-adju
Empire Company Limited (EMP.A:CA) Q2 2026 Earnings Call Transcript
11:42am, Thursday, 11'th Dec 2025
Empire Company Limited (EMP.A:CA) Q2 2026 Earnings Call Transcript
AtaiBeckley receives new US patent for oral R-MDMA formulation EMP-01
09:16am, Thursday, 11'th Dec 2025
AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) announced that the US Patent and Trademark Office has granted a new patent covering EMP-01, its oral R-MDMA formulation. The company said that the patent inclu
Empire Company Limited (EMP.A:CA) Annual General Meting Of Shareholders Call (Transcript)
03:37pm, Thursday, 11'th Sep 2025
Empire Company Limited (EMP.A:CA) Annual General Meting of Shareholders Call September 11, 2025 10:00 AM EDT Company Participants James Dickson - Director and Corporate Secretary of CS Manpar Inc Mich
Empire Company Limited (EMP.A:CA) Q1 2026 Earnings Call Transcript
11:16am, Thursday, 11'th Sep 2025
Empire Company Limited (EMP.A:CA) Q1 2026 Earnings Call September 11, 2025 8:30 AM EDT Company Participants Katie Brine - Director of Investor Relations Michael Medline - President, CEO & Director Con
Empire Company Limited (EMLAF) Q4 2025 Earnings Call Transcript
11:46am, Thursday, 19'th Jun 2025
Empire Company Limited (OTCPK:EMLAF) Q4 2025 Earnings Conference Call June 19, 2025 8:30 AM ET Company Participants Constantine Pefanis - Executive VP & CFO Katie Brine - Director of Investor Relation
atai Life Sciences doses first patient in Phase 2 social anxiety trial
09:32am, Tuesday, 13'th May 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has dosed the first patient in its Phase 2 clinical trial of EMP-01 for the treatment of social anxiety disorder (SAD). EMP-01, an oral for
atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
07:01am, Tuesday, 13'th May 2025
- In a Phase 1 study, EMP-01 (oral R-MDMA) demonstrated a unique, dose-dependent subjective effect profile that was generally found to be more similar to classical psychedelics than to racemic MDMA
Empire Company Limited (EMLAF) Q3 2025 Earnings Call Transcript
12:53pm, Thursday, 13'th Mar 2025
Empire Company Limited (OTCPK:EMLAF) Q3 2025 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Katie Brine - VP, IR Michael Medline - President and CEO Matt Reindel - CFO Pierre
Empire Company Limited (EMLAF) Q2 2025 Earnings Call Transcript
03:15pm, Thursday, 12'th Dec 2024
Call Start: 12:00 January 1, 0000 12:46 PM ET Empire Company Limited (OTCPK:EMLAF) Q2 2025 Earnings Conference Call December 12, 2024, 12:00 PM ET Company Participants Katie Brine - IR, Treasury & Pen
Empire Company Limited (EMLAF) Q1 2025 Earnings Call Transcript
03:30pm, Thursday, 12'th Sep 2024
Empire Company Limited (OTCPK:EMLAF) Q1 2025 Earnings Conference Call September 12, 2024 1:00 PM ET Corporate Participants Katie Brine - VP, IR Michael Medline - President and Chief Executive Officer
